These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 15747251
1. Use of RNA interference to prevent lethal murine west nile virus infection. Bai F, Wang T, Pal U, Bao F, Gould LH, Fikrig E. J Infect Dis; 2005 Apr 01; 191(7):1148-54. PubMed ID: 15747251 [Abstract] [Full Text] [Related]
2. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. J Infect Dis; 2005 Jan 15; 191(2):207-14. PubMed ID: 15609230 [Abstract] [Full Text] [Related]
3. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication. Ong SP, Choo BG, Chu JJ, Ng ML. Antiviral Res; 2006 Dec 15; 72(3):216-23. PubMed ID: 16870272 [Abstract] [Full Text] [Related]
4. Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine. Lim CK, Takasaki T, Kotaki A, Kurane I. Virology; 2008 Apr 25; 374(1):60-70. PubMed ID: 18221765 [Abstract] [Full Text] [Related]
5. Antiviral peptides targeting the west nile virus envelope protein. Bai F, Town T, Pradhan D, Cox J, Ashish, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E. J Virol; 2007 Feb 25; 81(4):2047-55. PubMed ID: 17151121 [Abstract] [Full Text] [Related]
9. Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. Widman DG, Ishikawa T, Fayzulin R, Bourne N, Mason PW. Vaccine; 2008 May 23; 26(22):2762-71. PubMed ID: 18423946 [Abstract] [Full Text] [Related]
12. Evaluation of synthetic oligonucleotides as inhibitors of West Nile virus replication. Torrence PF, Gupta N, Whitney C, Morrey JD. Antiviral Res; 2006 Jun 23; 70(2):60-5. PubMed ID: 16540182 [Abstract] [Full Text] [Related]
13. A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice. Wicker JA, Whiteman MC, Beasley DW, Davis CT, Zhang S, Schneider BS, Higgs S, Kinney RM, Barrett AD. Virology; 2006 Jun 05; 349(2):245-53. PubMed ID: 16624366 [Abstract] [Full Text] [Related]
14. West Nile virus neutralization by US plasma-derived immunoglobulin products. Planitzer CB, Modrof J, Kreil TR. J Infect Dis; 2007 Aug 01; 196(3):435-40. PubMed ID: 17597458 [Abstract] [Full Text] [Related]
16. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha. Martina BE, Koraka P, van den Doel P, Rimmelzwaan GF, Haagmans BL, Osterhaus AD. Virus Res; 2008 Jul 01; 135(1):64-71. PubMed ID: 18405996 [Abstract] [Full Text] [Related]